Skip to content

Millrace Asset Group, Inc.: ARHS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Millrace Asset Group, Inc. on ARHS, newest first. How the timeline and the estimate are built.

Millrace Asset Group, Inc. held 0 ARHS shares at 2024-09-30 per its 13F-HR filed 2024-11-13.

the latest 13F is the newest step

  1. period ended2024-09-30
    13F 0 shares
    Change vs previous 13F -17,506 shares

    13F-HR 0001604831-24-000005 filed by Millrace Asset Group, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2024-06-30
    13F 17,506 shares
    Change vs previous 13F -66,277 shares

    0.29% of the 13F portfolio, value $297,000.

    13F-HR 0001604831-24-000004 filed by Millrace Asset Group, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-03-31
    13F 83,783 shares
    Change vs previous 13F -26,464 shares

    1.3% of the 13F portfolio, value $1,289,000.

    13F-HR 0001604831-24-000003 filed by Millrace Asset Group, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2023-12-31
    13F 110,247 shares
    Change vs previous 13F -79,975 shares

    1.29% of the 13F portfolio, value $1,306,000.

    13F-HR 0001604831-24-000002 filed by Millrace Asset Group, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2023-09-30
    13F 190,222 shares
    Change vs previous 13F not available

    2.19% of the 13F portfolio, value $1,769,000.

    13F-HR 0001604831-23-000006 filed by Millrace Asset Group, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).